An independent analytical research newsletter that examines pharmaceutical open innovation, business development, M&A and corporate venture activity, using deal-level data and balance-sheet analysis. Recent issues dissect the external growth strategies of AstraZeneca, Eli Lilly and Novo Nordisk.
Weekly picks
Get the best new newsletters in your inbox
One short email a week with hand-picked newsletters from the index. Free, no spam, unsubscribe anytime.